Apogee Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VR ADVISER, LLC | 02/14/2025 | 8.49 M | $384.75 M | 0.00% | 15.39% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.04 M | $137.94 M | 2.32% | 5.52% |
RTW INVESTMENTS, LP | 02/14/2025 | 2.71 M | $122.86 M | 0.00% | 4.91% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 2.61 M | $118.02 M | 2.83% | 4.72% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 02/14/2025 | 2.05 M | $92.80 M | 0.00% | 3.71% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.57 M | $71.10 M | -20.00% | 2.84% |
BRAIDWELL LP | 02/14/2025 | 1.54 M | $69.78 M | -6.26% | 2.79% |
PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 1.28 M | $58.15 M | 82.92% | 2.33% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 1.05 M | $47.44 M | -48.03% | 1.90% |
WOODLINE PARTNERS LP | 02/14/2025 | 1.02 M | $46.01 M | 4.04% | 1.84% |
AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 931,728 | $42.21 M | 40.28% | 1.69% |
JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 887,497 | $40.20 M | 140.39% | 1.61% |
FRANKLIN RESOURCES INC | 02/12/2025 | 866,188 | $39.24 M | 0.60% | 1.57% |
SIREN, L.L.C. | 02/14/2025 | 747,325 | $33.85 M | 100.00% | 1.35% |
MERCER GLOBAL ADVISORS INC /ADV | 02/14/2025 | 720,101 | $32.62 M | 100.00% | 1.30% |
JENNISON ASSOCIATES LLC | 01/24/2025 | 312,391 | $14.15 M | -0.07% | 0.57% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 302,735 | $13.71 M | -57.20% | 0.55% |
LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 300,000 | $13.59 M | 100.00% | 0.54% |
COMMODORE CAPITAL LP | 02/14/2025 | 290,000 | $13.14 M | 0.00% | 0.53% |
FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 252,725 | $11.45 M | 100.00% | 0.46% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 240,200 | $10.88 M | 100.00% | 0.44% |
CAPITAL WORLD INVESTORS | 02/13/2025 | 205,100 | $9.29 M | 100.00% | 0.37% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 02/14/2025 | 172,711 | $7.82 M | -44.52% | 0.31% |
02/28/2025 | 143,952 | $6.52 M | 100.00% | 0.26% | |
TD ASSET MANAGEMENT INC | 02/11/2025 | 126,446 | $5.73 M | 35.31% | 0.23% |
ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 109,410 | $4.96 M | 0.00% | 0.20% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 100,000 | $4.53 M | 0.00% | 0.18% |
ALLOSTERY INVESTMENTS LP | 02/14/2025 | 100,000 | $4.53 M | 100.00% | 0.18% |
PLATINUM INVESTMENT MANAGEMENT LTD | 02/11/2025 | 95,646 | $4.33 M | -11.19% | 0.17% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 92,854 | $4.21 M | 1.20% | 0.17% |
02/14/2025 | 86,000 | $3.90 M | 100.00% | 0.16% | |
CANDRIAM S.C.A. | 02/07/2025 | 85,661 | $3.88 M | -4.82% | 0.16% |
PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 85,000 | $3.85 M | 100.00% | 0.15% |
BLACKSTONE INC. | 02/14/2025 | 80,000 | $3.62 M | 0.00% | 0.14% |
MARSHALL WACE, LLP | 02/13/2025 | 75,849 | $3.44 M | 1,963.92% | 0.14% |
KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 72,307 | $3.28 M | 75.53% | 0.13% |
SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 70,766 | $3.21 M | 100.00% | 0.13% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 70,000 | $3.17 M | 100.00% | 0.13% |
ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 69,750 | $3.16 M | 0.00% | 0.13% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 58,466 | $2.61 M | 0.00% | 0.11% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 57,673 | $2.61 M | 5.70% | 0.10% |
02/14/2025 | 50,620 | $2.29 M | 100.00% | 0.09% | |
HIGHVISTA STRATEGIES LLC | 02/14/2025 | 43,190 | $1.96 M | -30.10% | 0.08% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 41,274 | $1.87 M | -27.82% | 0.07% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 41,106 | $1.86 M | -1.54% | 0.07% |
NEO IVY CAPITAL MANAGEMENT | 02/18/2025 | 38,523 | $1.75 M | 100.00% | 0.07% |
ALPS ADVISORS INC | 02/13/2025 | 36,410 | $1.65 M | 2.61% | 0.07% |
SQUAREPOINT OPS LLC | 02/14/2025 | 36,344 | $1.65 M | 90.85% | 0.07% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 25,000 | $1.13 M | 0.00% | 0.05% |
02/10/2025 | 24,000 | $1.10 M | 100.00% | 0.04% |
Apogee Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 100 institutional investors and hedge funds held shares of Apogee Therapeutics, Inc.. The most heavily invested institutionals were:
VR Adviser, LLC: 8.49 M
BlackRock Funding, Inc. /DE: 3.04 M
RTW INVESTMENTS, LP: 2.71 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 2.61 M
Fairmount Funds Management LLC: 2.05 M
RA CAPITAL MANAGEMENT, L.P.: 1.57 M
104.85% of Apogee Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 34.23 M shares in the last 24 months. This purchase volume represents approximately $1.65 B in transactions.